Resveratrol-loaded microemulsion based thermosensitive hydrogel for potential topical treatment of the vaginal inflammation

References

• Onderdonk A, Delaney M, Fichorova R. The human microbiome during bacterial vaginosis. Clin Microbiol Rev. 2016;29(2):223–238. doi:10.1128/CMR.00075-15.
   PubMed Web of Science ®Google Scholar
• Gigi R, Buitrago-Garcia D, Taghavi K, et al. Vulvovaginal yeast infections during pregnancy and perinatal outcomes: systematic review and meta-analysis. BMC Womens Health. 2023;23(1):116. doi:10.1186/s12905-023-02258-7.
   PubMed Web of Science ®Google Scholar
• Paladine HL, Desai UA. Vaginitis: diagnosis and treatment. Am Fam Physician. 2018;97(5):321–329.
   PubMed Web of Science ®Google Scholar
• Mallo N, Lamas J, Leiro JM. Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against trichomonas vaginalis. Antimicrob Agents Chemother. 2013;57(6):2476–2484. doi:10.1128/AAC.00009-13.
   PubMed Web of Science ®Google Scholar
• Frémont L. Biological effects of resveratrol. Life Sci. 2000;66(8):663–673. doi:10.1016/s0024-3205(99)00410-5.
   PubMed Web of Science ®Google Scholar
• Pannu N, Bhatnagar A. Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases. Biomed Pharmacother. 2019;109:2237–2251. doi:10.1016/j.biopha.2018.11.075.
   PubMed Web of Science ®Google Scholar
• Abbasi Oshaghi E, Goodarzi M, Higgins V, et al. Role of resveratrol in the management of insulin resistance and related conditions: mechanism of action. Crit Rev Clin Lab Sci. 2017;54(4):267–293. doi:10.1080/10408363.2017.1343274.
   PubMed Web of Science ®Google Scholar
• Dull AM, Moga MA, Dimienescu OG, et al. Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways. Molecules. 2019;24(4):667. doi:10.3390/molecules24040667.
   PubMed Web of Science ®Google Scholar
• Negi P, Aggarwal M, Sharma G, et al. Niosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s). Biomed Pharmacother. 2017;88:480–487. doi:10.1016/j.biopha.2017.01.083.
   PubMed Web of Science ®Google Scholar
• Bariani MV, Correa F, Leishman E, et al. Resveratrol protects from lipopolysaccharide-induced inflammation in the uterus and prevents experimental preterm birth. Mol Hum Reprod. 2017;23(8):571–581. doi:10.1093/molehr/gax036.
   PubMed Web of Science ®Google Scholar
• Jøraholmen MW, Škalko-Basnet N, Acharya G, et al. Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections. Eur J Pharm Sci. 2015;79:112–121. doi:10.1016/j.ejps.2015.09.007.
   PubMed Web of Science ®Google Scholar
• Jøraholmen MW, Johannessen M, Gravningen K, et al. Liposomes-in-hydrogel delivery system enhances the potential of resveratrol in combating vaginal chlamydia infection. Pharmaceutics. 2020;12(12):1203. doi:10.3390/pharmaceutics12121203.
   PubMed Web of Science ®Google Scholar
• Nikolic D, Piguet V. Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission. J Invest Dermatol. 2010;130(2):352–361. doi:10.1038/jid.2009.227.
   PubMed Web of Science ®Google Scholar
• Das S, Lin H, Ho P, et al. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm Res. 2008;25(11):2593–2600. doi:10.1007/s11095-008-9677-1.
   PubMed Web of Science ®Google Scholar
• Kalita B, Das MK, Sarma M, et al. Sustained anti-inflammatory effect of resveratrol-phospholipid complex embedded polymeric patch. AAPS PharmSciTech. 2017;18(3):629–645. doi:10.1208/s12249-016-0542-y.
   PubMed Web of Science ®Google Scholar
• Al Saqr A, Annaji M, Poudel I, et al. Topical delivery of diacetyl boldine in a microemulsion formulation for chemoprotection against melanoma. Pharmaceutics. 2023;15(3):901. doi:10.3390/pharmaceutics15030901.
   PubMed Web of Science ®Google Scholar
• Rangsimawong W, Wattanasri P, Tonglairoum P, et al. Development of microemulsions and microemulgels for enhancing transdermal delivery of kaempferia parviflora extract. AAPS PharmSciTech. 2018;19(5):2058–2067. doi:10.1208/s12249-018-1003-6.
   PubMed Web of Science ®Google Scholar
• Tabosa M, de Andrade A, Lira A, et al. Microemulsion formulations for the transdermal delivery of lapachol. AAPS PharmSciTech. 2018;19(4):1837–1846. doi:10.1208/s12249-018-0995-2.
   PubMed Web of Science ®Google Scholar
• Vanić Ž, Škalko-Basnet N. Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur J Pharm Sci. 2013;50(1):29–41. doi:10.1016/j.ejps.2013.04.035.
   PubMed Web of Science ®Google Scholar
• Pavelić Z, Skalko-Basnet N, Schubert R. Liposomal gels for vaginal drug delivery. Int J Pharm. 2001;219(1-2):139–149. doi:10.1016/s0378-5173(01)00637-8.
   PubMed Web of Science ®Google Scholar
• Frank LA, Sandri G, D’Autilia F. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery. Int J Nanomed. 2014;9:3151–3161.
   PubMed Web of Science ®Google Scholar
• Taurin S, Almomen AA, Pollak T, et al. Thermosensitive hydrogels a versatile concept adapted to vaginal drug delivery. J Drug Target. 2017;26(7):533–550. doi:10.1080/1061186X.2017.1400551.
   PubMed Web of Science ®Google Scholar
• Deng H, Dong A, Song J, et al. Injectable thermosensitive hydrogel systems based on functional PEG/PCL block polymer for local drug delivery. J Control Release. 2019;297:60–70. doi:10.1016/j.jconrel.2019.01.026.
   PubMed Web of Science ®Google Scholar
• Jøraholmen M, Basnet P, Acharya G, et al. PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha. Eur J Pharm Biopharm. 2017;113:132–139. doi:10.1016/j.ejpb.2016.12.029.
   PubMed Web of Science ®Google Scholar
• Gegel NO, Shipovskaya AB, Khaptsev ZY, et al. Thermosensitive chitosan-containing hydrogels: their formation, properties, antibacterial activity, and veterinary usage. Gels. 2022;8(2):93. doi:10.3390/gels8020093.
   PubMed Web of Science ®Google Scholar
• Kotta S, Aldawsari HM, Badr-Eldin SM, et al. Thermosensitive hydrogels loaded with resveratrol nanoemulsion: formulation optimization by central composite design and evaluation in MCF-7 human breast cancer cell lines. Gels. 2022;8(7):450. doi:10.3390/gels8070450.
   PubMed Web of Science ®Google Scholar
• Li JY, Feng YH, He YT, et al. Thermosensitive hydrogel microneedles for controlled transdermal drug delivery. Acta Biomater. 2022;153:308–319. doi:10.1016/j.actbio.2022.08.061.
   PubMed Web of Science ®Google Scholar
• Norouzi M, Nazari B, Miller DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. 2016;21(11):1835–1849. doi:10.1016/j.drudis.2016.07.006.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Yan M, et al. Thermosensitive hydrogel based on poly(2-Ethyl-2-Oxazoline)-poly(D,L-Lactide)-poly(2-Ethyl-2-Oxazoline) for sustained salmon calcitonin delivery. AAPS PharmSciTech. 2020;21(2):71. doi:10.1208/s12249-020-1619-1.
   PubMed Web of Science ®Google Scholar
• Mirza MA, Ahmad S, Mallick MN, et al. Development of a novel synergistic thermosensitive gel for vaginal candidiasis: an in vitro, in vivo evaluation. Colloids Surf B Biointerfaces. 2013;103:275–282. doi:10.1016/j.colsurfb.2012.10.038.
   PubMed Web of Science ®Google Scholar
• Sovrani V, de Jesus LI, Simas-Tosin FF, et al. Structural characterization and rheological properties of a gel-like β-d-glucan from pholiota nameko. Carbohydr Polym. 2017;169:1–8. doi:10.1016/j.carbpol.2017.03.093.
   PubMed Web of Science ®Google Scholar
• Arkin A, Elham A, Anwar A, et al. Optimization and evaluation of the quercus infectoria galls thermosensitive in situ gel for rectal delivery. J Evid-Based Complement Alternat Med. 2022;2022:1–15. doi:10.1155/2022/8451055.
   Google Scholar
• Su J, Ma J, Mo F, et al. Thermosensitive hydrogels as a controlled release system for alkannin to improve localized treatment of Candida vaginitis after external beam radiotherapy in vitro and in vivo. Pathog Dis. 2019;77(4):ftz041.
   PubMed Web of Science ®Google Scholar
• Li N, Yu M, Deng L, et al. Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery. J Mater Sci Mater Med. 2012;23(8):1913–1919. doi:10.1007/s10856-012-4664-9.
   PubMed Web of Science ®Google Scholar
• Jøraholmen MW, Basnet P, Tostrup MJ, et al. Localized therapy of vaginal infections and inflammation: liposomes-in-hydrogel delivery system for polyphenols. Pharmaceutics. 2019;11(2):53. doi:10.3390/pharmaceutics11020053.
   PubMed Web of Science ®Google Scholar
• Singh KK, Parmar S, Tatke PA. Contraceptive efficacy and safety of HerbOshield vaginal gel in rats. Contraception. 2012;85(1):122–127. doi:10.1016/j.contraception.2011.04.013.
   PubMed Web of Science ®Google Scholar
• Mirza MA, Panda AK, Asif S, et al. A vaginal drug delivery model. Drug Deliv. 2016;23(8):3123–3134. doi:10.3109/10717544.2016.1153749.
   PubMed Web of Science ®Google Scholar
• Mohideen M, Quijano E, Song E, et al. Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir. Biomaterials. 2017;144:144–154. doi:10.1016/j.biomaterials.2017.08.029.
   PubMed Web of Science ®Google Scholar
• Li WZ, Hao XL, Zhao N, et al. Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications. J Control Release. 2016;226:107–114. doi:10.1016/j.jconrel.2016.02.024.
   PubMed Web of Science ®Google Scholar
• Gokce EH, Korkmaz E, Dellera E, et al. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomed. 2012;7:1841–1850. doi:10.2147/IJN.S29710.
   PubMed Web of Science ®Google Scholar
• Ci T, Yuan L, Bao X, et al. Development and anti-candida evaluation of the vaginal delivery system of amphotericin B nanosuspension-loaded thermogel. J Drug Target. 2018;26(9):829–839. doi:10.1080/1061186X.2018.1434660.
   PubMed Web of Science ®Google Scholar
• Timur SS, Şahin A, Aytekin E, et al. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections. Pharm Dev Technol. 2017;23(3):301–310. doi:10.1080/10837450.2017.1329835.
   PubMed Web of Science ®Google Scholar
• Rashad AL, Toffler WL, Wolf N, et al. Vaginal Po2 in healthy women and in women infected withTrichomonas ­vaginalis: potential implications for metronidazole therapy. Am J Obstet Gynecol. 1992;166(2):620–624. doi:10.1016/0002-9378(92)91687-6.
   PubMed Web of Science ®Google Scholar
• Tain Y-L, Jheng L-C, Chang SKC, et al. Synthesis and characterization of novel resveratrol butyrate esters that have the ability to prevent fat accumulation in a liver cell culture model. Molecules. 2020;25(18):4199. doi:10.3390/molecules25184199.
   PubMed Web of Science ®Google Scholar
• Patole VC, Awari D, Chaudhari S. Resveratrol-loaded microsponge gel for wound healing: in vitro and in vivo characterization. Turk J Pharm Sci. 2023;20(1):23–34. doi:10.4274/tjps.galenos.2022.93275.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun K, Chen S, et al. Nano-resveratrol liposome: physicochemical stability, in vitro release, and cytotoxicity. Appl Biochem Biotechnol. 2023;195(10):5950–5965. doi:10.1007/s12010-023-04344-w.
   PubMedGoogle Scholar
• Rohani Shirvan A, Hemmatinejad N, Bahrami SH, et al. Fabrication of multifunctional mucoadhesive buccal patch for drug delivery applications. J Biomed Mater Res A. 2021;109(12):2640–2656. doi:10.1002/jbm.a.37257.
   PubMed Web of Science ®Google Scholar
• Oberoi G, Müller A, Moritz A, et al. Titanium dioxide-based scanning powder can modulate cell activity of oral soft tissue - insights from in vitro studies with L929 cells and periodontal fibroblasts. J Prosthodont Res. 2020;64(1):34–42. doi:10.1016/j.jpor.2019.05.001.
   PubMed Web of Science ®Google Scholar
• He J, Wang T, Yao L, et al. Construction and delivery of gene therapy vector containing soluble TNFα receptor-IgGFc fusion gene for the treatment of allergic rhinitis. Cytokine. 2006;36(5–6):296–304. doi:10.1016/j.cyto.2007.02.010.
   PubMed Web of Science ®Google Scholar
• Jalalvandi E, Cabral J, Hanton LR, et al. Cyclodextrin-polyhydrazine degradable gels for hydrophobic drug delivery. Mater Sci Eng C Mater Biol Appl. 2016;69:144–153. doi:10.1016/j.msec.2016.06.058.
   PubMed Web of Science ®Google Scholar